Managing Drug-Risk Information - What to Do with All Those New Numbers

被引:29
作者
Avorn, Jerry [1 ]
Schneeweiss, Sebastian
机构
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
关键词
D O I
10.1056/NEJMp0905466
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:647 / 649
页数:4
相关论文
共 5 条
[1]   INCREASED ANTIDEPRESSANT USE IN PATIENTS PRESCRIBED BETA-BLOCKERS [J].
AVORN, J ;
EVERITT, DE ;
WEISS, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (03) :357-360
[2]  
Avorn J., 2005, Powerful medicines: The benefits, risks, and costs of prescription drugs, DOI DOI 10.1200/JOP.2014.003194
[3]   Exhaustion, Automation, Theory, and Confounding [J].
Joffe, Marshall M. .
EPIDEMIOLOGY, 2009, 20 (04) :523-524
[4]   A review of uses of health care utilization databases for epidemiologic research on therapeutics [J].
Schneeweiss, S ;
Avorn, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2005, 58 (04) :323-337
[5]  
Wood R, 1997, Popul Trends, P5